[MDGL] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
06-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -15.08%
YoY- -19.40%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 14,638 0 770 0 0 0 0 -
PBT -151,971 -147,541 -112,194 -98,740 -85,800 -76,896 -85,905 46.32%
Tax 0 0 98 -135 3,425 896 1,682 -
NP -151,971 -147,541 -112,194 -98,740 -85,800 -77,792 -87,587 44.44%
Tax Rate - - - - - - - -
Total Cost 166,609 147,541 112,964 98,740 85,800 77,792 87,587 53.58%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -1,038.20 0.00 -14,570.65 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -7.10 -7.38 -5.68 -5.34 -4.69 -4.28 -5.08 25.03%
EPS Diluted -7.10 -7.38 -5.68 -5.34 -4.69 -4.28 -5.08 25.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.